13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-13, with 67 holding rows worth $352,567,364.
- Accession
- 0001420506-25-000357
- Filer
- CIK 1746382
- Filed
- 2025-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 67 entries on the cover page, a total value of $352,567,364 stated on the cover page (in dollars after the unit check, H1), rows summing to $352,567,364 with VALUE read as dollars as filed, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ADMA BIOLOGICS INC | 000899104 | COM | 1,395,000 | $23,924,250 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 432,000 | $18,269,280 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 127,000 | $15,441,930 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 1,850,000 | $15,429,000 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 305,000 | $14,051,350 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 300,000 | $13,821,000 | dollars as filed | call |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 300,000 | $12,966,000 | dollars as filed | call |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 165,000 | $12,214,950 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 288,000 | $11,289,600 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 250,000 | $11,237,500 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 714,000 | $9,853,200 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 285,000 | $9,798,300 | dollars as filed | |
| MERIT MED SYS INC COM | 589889104 | Stock | 100,000 | $9,672,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 250,000 | $9,337,500 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 132,000 | $9,113,280 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,694,000 | $8,300,600 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 685,000 | $7,562,400 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 75,000 | $6,264,000 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 10,000 | $6,150,000 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 40,000 | $5,997,600 | dollars as filed | |
| RESMED INC COM | 761152107 | Stock | 26,000 | $5,945,940 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 146,000 | $5,875,040 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 100,000 | $5,619,000 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 815,000 | $5,533,850 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,424,400 | $5,384,232 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 255,000 | $5,321,850 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 334,000 | $4,893,100 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 370,000 | $4,891,400 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,579,000 | $4,847,530 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 452,475 | $4,755,512 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 385,000 | $4,543,000 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 230,257 | $4,328,832 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 737,000 | $4,112,460 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 485,000 | $3,642,350 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 7,415,413 | $3,285,028 | dollars as filed | |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 1,139,000 | $3,223,370 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 355,000 | $2,864,850 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 95,000 | $2,859,500 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 3,000,000 | $2,790,000 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 175,000 | $2,770,250 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 206,200 | $2,730,088 | dollars as filed | put |
| IMMUNITYBIO INC | 45256X103 | COM | 1,060,000 | $2,713,600 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 405,000 | $2,664,900 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 475,000 | $2,631,500 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 60,000 | $2,624,400 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 1,428,000 | $2,556,120 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 264,562 | $2,428,679 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 505,000 | $1,954,350 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 218,386 | $1,878,120 | dollars as filed | |
| ALPHA COGNITION INC | 02074J501 | COM NEW | 275,000 | $1,619,750 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 396,000 | $1,532,520 | dollars as filed | call |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 575,000 | $1,523,750 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 2,028,534 | $1,319,561 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 1,473,000 | $1,169,857 | dollars as filed | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 310,000 | $936,200 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 40,352 | $564,928 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 581,395 | $551,046 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 111,812 | $525,516 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 740,000 | $500,462 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 467,491 | $481,516 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 9,400 | $368,480 | dollars as filed | call |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 92,224 | $294,195 | dollars as filed | |
| SRX GLOBAL INC | 08771Y402 | COM NEW | 118,459 | $278,379 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 18,326 | $242,636 | dollars as filed | |
| QUOIN PHARMACEUTICALS ADR | 74907L300 | COM | 282,249 | $183,659 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F807 | COM | 215,000 | $64,285 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 56,100 | $48,033 | dollars as filed | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-000357 | this filing | 2025-02-13 | acceptance time not in the bulk data set |